BACKGROUND: Transmembrane protease serine 4 (TMPRSS4), one of the type II transmembrane serine proteases (TTSPs), is elevated in various cancers and is associated with multiple malignant phenotypes. However, the expression pattern and biologic significance of TMPRSS4 in thyroid cancer are largely unknown. In this study, we investigated the expression of TMPRSS4 in thyroid cancer and assessed the pro-proliferative role of TMPRSS4 in thyroid cancer. METHODS: Immunohistochemistry and real-time reverse transcription-polymerase chain reaction (RT-PCR) assays were performed to assess the expression of TMPRSS4 in thyroid cancer. We evaluated in vitro cell proliferation using MTT, colony formation, anchorage-independent growth, flow cytometry analysis, and 5-ethynyl-2'-deoxyuridine (EdU) incorporation assays. Western blot, real-time RT-PCR, and luciferase assays were conducted to reveal the underlying mechanisms. RESULTS: TMPRSS4 is overexpressed in thyroid cancer and is associated with the grade of malignancy. Depletion of TMPRSS4 in thyroid cancer cells significantly suppressed proliferation. Moreover, the proliferation of thyroid cancer cells with TMPRSS4 overexpression was significantly enhanced. We also show that cyclic adenosine monophosphate response element-binding protein (CREB)-cyclin D1 signaling mediates, at least partially, the role of TMPRSS4 in thyroid cancer cell proliferation. CONCLUSIONS: TMPRSS4 is overexpressed in thyroid cancer and TMPRSS4-CREB signaling is needed to sustain thyroid cancer cell proliferation.
BACKGROUND:Transmembrane protease serine 4 (TMPRSS4), one of the type II transmembrane serine proteases (TTSPs), is elevated in various cancers and is associated with multiple malignant phenotypes. However, the expression pattern and biologic significance of TMPRSS4 in thyroid cancer are largely unknown. In this study, we investigated the expression of TMPRSS4 in thyroid cancer and assessed the pro-proliferative role of TMPRSS4 in thyroid cancer. METHODS: Immunohistochemistry and real-time reverse transcription-polymerase chain reaction (RT-PCR) assays were performed to assess the expression of TMPRSS4 in thyroid cancer. We evaluated in vitro cell proliferation using MTT, colony formation, anchorage-independent growth, flow cytometry analysis, and 5-ethynyl-2'-deoxyuridine (EdU) incorporation assays. Western blot, real-time RT-PCR, and luciferase assays were conducted to reveal the underlying mechanisms. RESULTS:TMPRSS4 is overexpressed in thyroid cancer and is associated with the grade of malignancy. Depletion of TMPRSS4 in thyroid cancer cells significantly suppressed proliferation. Moreover, the proliferation of thyroid cancer cells with TMPRSS4 overexpression was significantly enhanced. We also show that cyclic adenosine monophosphate response element-binding protein (CREB)-cyclin D1 signaling mediates, at least partially, the role of TMPRSS4 in thyroid cancer cell proliferation. CONCLUSIONS:TMPRSS4 is overexpressed in thyroid cancer and TMPRSS4-CREB signaling is needed to sustain thyroid cancer cell proliferation.
Authors: C Wallrapp; S Hähnel; F Müller-Pillasch; B Burghardt; T Iwamura; M Ruthenbürger; M M Lerch; G Adler; T M Gress Journal: Cancer Res Date: 2000-05-15 Impact factor: 12.701
Authors: Barbara Jarzab; Malgorzata Wiench; Krzysztof Fujarewicz; Krzysztof Simek; Michal Jarzab; Malgorzata Oczko-Wojciechowska; Jan Wloch; Agnieszka Czarniecka; Ewa Chmielik; Dariusz Lange; Agnieszka Pawlaczek; Sylwia Szpak; Elzbieta Gubala; Andrzej Swierniak Journal: Cancer Res Date: 2005-02-15 Impact factor: 12.701
Authors: H Jung; K P Lee; S J Park; J H Park; Y-S Jang; S-Y Choi; J-G Jung; K Jo; D Y Park; J H Yoon; J-H Park; D-S Lim; G-R Hong; C Choi; Y-K Park; J W Lee; H J Hong; S Kim; Y W Park Journal: Oncogene Date: 2007-10-29 Impact factor: 9.867
Authors: Caroline M Forrest; Kara McNair; Maria C J Vincenten; L Gail Darlington; Trevor W Stone Journal: BMC Cancer Date: 2016-10-06 Impact factor: 4.430